Tag Archives: cancer expenses

New Cancer Drug Zaltrap Discounted by 50%

By Curt Pesman and Mary Miller In an unusual move, sanofi pharmaceutical company has instituted a 50 percent discount, effective immediately, on its latest cancer drug Zaltrap.  The reason for the sharp price drop, company officials said, was “market resistance” to the initial price. Zaltrap was approved in August by the FDA for second-line treatment for metastatic colorectal cancer. One possible result of the price cut is that the new drug may become more widely available. However, due to complex pricing and regulation issues, it’s not yet known how the actual cost to patients will change over the next several months. Fight Colorectal Cancer is gathering more information today on this

Cancer Costs Grow, But Stay in Line with Other Medical Expense

Over the past twenty years, the cost of caring for cancer patients doubled, but still remained about 5 percent of all medical expense in the United States. An increase in the number of people with cancer — fueled by an aging population — drove the growing expense rather than a greater cost per individual. Expressed in 2007 dollars, out-of-pocket costs for patients and their families fell, while the costs paid by private insurance and Medicaid rose.  Average Medicaid expense in from 2001 though 2005 was almost five times as high as 1987, while Medicare costs doubled.